Insider Selling: Novanta (NASDAQ:NOVT) CFO Sells 9,957 Shares of Stock

Novanta Inc. (NASDAQ:NOVT) CFO Robert Buckley sold 9,957 shares of the stock in a transaction dated Monday, March 16th. The shares were sold at an average price of $116.77, for a total value of $1,162,678.89. Following the completion of the sale, the chief financial officer directly owned 96,616 shares of the company’s stock, valued at approximately $11,281,850.32. The trade was a 9.34% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this link.

Robert Buckley also recently made the following trade(s):

• On Friday, February 20th, Robert Buckley sold 1,423 shares of Novanta stock. The stock was sold at an average price of $140.88, for a total transaction of $200,472.24.
• On Wednesday, January 21st, Robert Buckley sold 1,423 shares of Novanta stock. The stock was sold at an average price of $140.14, for a total transaction of $199,419.22.

Novanta Trading Down 1.4%

Shares of NASDAQ:NOVT traded down $1.69 during trading on Wednesday, reaching $119.33. The stock had a trading volume of 569,434 shares, compared to its average volume of 457,808. Novanta Inc. has a 52 week low of $98.27 and a 52 week high of $149.95. The company has a debt-to-equity ratio of 0.16, a quick ratio of 2.80 and a current ratio of 3.69. The firm’s fifty day moving average is $135.34 and its 200 day moving average is $121.22. The stock has a market cap of $4.26 billion, a price-to-earnings ratio of 81.73 and a beta of 1.61.

Novanta (NASDAQ:NOVT) last announced its earnings results on Monday, February 23rd. The technology company reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.88 by $0.03. The business had revenue of $258.35 million during the quarter, compared to the consensus estimate of $260.72 million. Novanta had a net margin of 5.49% and a return on equity of 13.12%. During the same quarter last year, the firm earned $0.76 earnings per share. Novanta has set its FY 2026 guidance at 3.500-3.650 EPS and its Q1 2026 guidance at 0.750-0.800 EPS. As a group, equities analysts forecast that Novanta Inc. will post 3.03 EPS for the current fiscal year.

Institutional Investors Weigh In On Novanta

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Rockefeller Capital Management L.P. raised its holdings in shares of Novanta by 155.6% during the fourth quarter. Rockefeller Capital Management L.P. now owns 662 shares of the technology company’s stock valued at $79,000 after purchasing an additional 403 shares during the period. Corient Private Wealth LLC acquired a new stake in shares of Novanta in the 4th quarter valued at about $275,000. Hsbc Holdings PLC increased its position in Novanta by 1,355.6% in the 4th quarter. Hsbc Holdings PLC now owns 185,155 shares of the technology company’s stock valued at $21,964,000 after buying an additional 172,435 shares in the last quarter. Invesco Ltd. increased its position in Novanta by 9.0% in the 4th quarter. Invesco Ltd. now owns 68,089 shares of the technology company’s stock valued at $8,102,000 after buying an additional 5,600 shares in the last quarter. Finally, Alberta Investment Management Corp acquired a new position in Novanta during the 4th quarter worth approximately $1,285,000. 98.35% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on the company. Weiss Ratings raised Novanta from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Tuesday, January 20th. Zacks Research upgraded Novanta from a “strong sell” rating to a “hold” rating in a report on Friday, January 16th. Finally, Robert W. Baird set a $150.00 price target on Novanta in a research note on Wednesday, February 25th. Three investment analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $150.00.

About Novanta

Novanta, Inc (NASDAQ: NOVT) is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta’s product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.

Novanta’s Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.